. Author manuscript; available in PMC: 2020 Jul 10.

Published in final edited form as: J Rheumatol. 2016 Jun 1;43(8):1559–1565. doi: 10.3899/jrheum.151033

Table 4.

Conditional regression analysis showing predictors of visual complication in patients with biopsy-proven GCA.

Predictors	Univariate Analysis			Multivariate Analysis
Predictors	OR	95% CI	P	OR	95% CI	P
Headache	033	0.13–0.84	0.02	0.36	0.09–1.47	0.15
Fever	0.50	0.20–1.23	0.13	0.48	0.13–1.69	0.25
Abnormal temporal artery^*	0.42	0.20–0.85	0.01	1.19	0.28–4.98	0.80
PMR symptoms at diagnosis	0.47	0.21–1.04	0.06	0.32	0.05–1.91	0.21
PMR diagnosis before GCA	2.11	0.95–4.66	0.06	0.96	0.19–.68	0.96
ACE/ARB	1.88	0.84–4.23	0.12	2.52	0.60–10.4	0.20
β-adrenergic inhibitors	2.77	1.29–5.95	0.009	6.98	1.29–37.8	0.02

On clinical examination. Significant data are in bold face. GCA: giant cell arteritis; PMR: polymyalgia rheumatica; ACE/ARB: angiotensin-converting enzyme inhibitor/angiotensin II receptor blockers.